标题
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs
作者
关键词
-
出版物
PPAR Research
Volume 2016, Issue -, Pages 1-10
出版商
Hindawi Limited
发表日期
2016-10-06
DOI
10.1155/2016/3038164
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
- (2016) Roberto Würth et al. DRUG DISCOVERY TODAY
- In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors
- (2015) Federica Barbieri et al. BMC CANCER
- Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle
- (2015) Vladimir Ljubicic et al. MUSCLE & NERVE
- Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA
- (2015) Serena Vella et al. Scientific Reports
- Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells
- (2015) Tarek H. Mouhieddine et al. Frontiers in Neuroscience
- Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
- (2015) Igor Vujic et al. Oncotarget
- Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma
- (2015) Ambrish Kumar et al. Oncotarget
- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
- (2015) Marta Gritti et al. Oncotarget
- Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5′ Adenosine Monophosphate–Activated Protein Kinase–Peroxisome Proliferator–Activated Receptor δ Pathway
- (2014) Wai San Cheang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Silencing histone deacetylase 2 using small hairpin RNA induces regression of fibrotic plaque in a rat model of Peyronie's disease
- (2014) Ki-Dong Kwon et al. BJU INTERNATIONAL
- Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA
- (2014) Delfina Costa et al. Cancer Cell International
- Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians
- (2013) Amir Qaseem et al. ANNALS OF INTERNAL MEDICINE
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
- (2013) F. Morgillo et al. CLINICAL CANCER RESEARCH
- Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathway
- (2013) Ming-Chang Chiang et al. MITOCHONDRION
- NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion
- (2012) Sara Massone et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions
- (2012) L. Vitale-Cross et al. Cancer Prevention Research
- Metformin selectively affects human glioblastoma tumor-initiating cell viability
- (2012) Roberto Würth et al. CELL CYCLE
- Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
- (2012) Mi Young Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells
- (2012) Marianna Terrasi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Probing cytoskeleton organisation of neuroblastoma cells with single-cell force spectroscopy
- (2012) Andrea Mescola et al. JOURNAL OF MOLECULAR RECOGNITION
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Activated AMPK inhibits PPAR-α and PPAR-γ transcriptional activity in hepatoma cells
- (2011) Margaret S. Sozio et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
- (2011) Claudia Sedlinsky et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Link between metformin and the peroxisome proliferator-activated receptor γ pathway in the uterine tissue of hyperandrogenized prepubertal mice
- (2011) Evelin M. Elia et al. FERTILITY AND STERILITY
- Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA
- (2011) Paola Gavazzo et al. JOURNAL OF NEUROCHEMISTRY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- In vivo effects of rosiglitazone in a human neuroblastoma xenograft
- (2010) I Cellai et al. BRITISH JOURNAL OF CANCER
- Neuroblastoma: Therapeutic strategies for a clinical enigma
- (2010) Shakeel Modak et al. CANCER TREATMENT REVIEWS
- Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice
- (2010) A. Maida et al. DIABETOLOGIA
- An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells
- (2010) Manuele Castelnuovo et al. FASEB JOURNAL
- Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo
- (2010) Jose A. Morales-Garcia et al. GLIA
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Effect of the PPAR-γ Agonist Rosiglitazone on Neuroblastoma SK-N-SH Cells in a Metastatic Xenograft Mouse Model
- (2010) Nina Krieger-Hinck et al. ONCOLOGY RESEARCH
- PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors
- (2010) Elisabetta Benedetti et al. PPAR Research
- The peroxisome proliferator-activated receptor-α (PPAR-α) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
- (2009) Wolfgang Linz et al. ACTA PHARMACOLOGICA SINICA
- Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
- (2009) K. Kisfalvi et al. CANCER RESEARCH
- Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
- (2009) R. Rattan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells
- (2009) Gianluca Miglio et al. NEUROSCIENCE LETTERS
- Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells
- (2009) Qiuju Chen et al. Reproductive Biology and Endocrinology
- Glucose represses PPARαgene expression via AMP-activated protein kinase but not via p38 mitogen-activated protein kinase in the pancreatic β-cell
- (2009) Erik JOLY et al. Journal of Diabetes
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
- (2008) C. Algire et al. ENDOCRINE-RELATED CANCER
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons
- (2008) J. Brodbeck et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARγin Neuroblastoma
- (2008) Alessandro Peri et al. PPAR Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now